Cargando…

OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation

BACKGROUND: The once-daily (QD), prolonged-release formulation of tacrolimus has been shown to improve adherence versus twice-daily (BD) tacrolimus. Treatment nonadherence in transplant recipients has been associated with poor graft outcomes. METHODS: This open-label, parallel-group study randomized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albano, Laetitia, Banas, Bernhard, Klempnauer, Juergen L., Glyda, Maciej, Viklicky, Ondrej, Kamar, Nassim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2013
Materias:	Clinical and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864174/ https://www.ncbi.nlm.nih.gov/pubmed/23982340 http://dx.doi.org/10.1097/TP.0b013e3182a203bd

Ejemplares similares

Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors – A Post Hoc Analysis of the Prospective OSAKA Study
por: Albano, Laetitia, et al.
Publicado: (2020)

The OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation: Erratum
Publicado: (2014)

Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial
por: Mourad, Georges, et al.
Publicado: (2017)

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe
por: Budde, Klemens, et al.
Publicado: (2022)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation
por: Sobiak, Joanna, et al.
Publicado: (2015)

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients
por: Gaber, A. Osama, et al.
Publicado: (2013)

Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
por: Silva, Hélio Tedesco, et al.
Publicado: (2014)

Analysis of Factors Affecting Employment Status of Kidney Transplant Recipients in Selected European Union Member States
por: Wlodarczyk, Elzbieta, et al.
Publicado: (2021)

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study
por: Garaix, Florentine, et al.
Publicado: (2018)

QD0 Design
por: Modena, Michele
Publicado: (2013)

QD0 Design
por: Modena, Michele
Publicado: (2013)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Editorial: Advances in the diagnosis and treatment in kidney transplantation
por: Eller, Kathrin, et al.
Publicado: (2022)

Interventional Trial for Colorectal Cancer Prevention in Osaka: An Introduction to the Protocol
por: Ishikawa, Hideki, et al.
Publicado: (1995)

Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
por: Undre, Nasrullah, et al.
Publicado: (2021)

Spotlight on Osaka
Publicado: (2009)

Spotlight on Osaka
Publicado: (2005)

Complement in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2017)

Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation
por: Grossi, Paolo Antonio, et al.
Publicado: (2022)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years
por: Saliba, Faouzi, et al.
Publicado: (2019)

Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients
por: Kamar, Nassim
Publicado: (2011)

LiQD Cornea: Pro-regeneration collagen mimetics as patches and alternatives to corneal transplantation
por: McTiernan, Christopher D., et al.
Publicado: (2020)

CLIC QD0 "Short Prototype" Status
por: Modena, Michele
Publicado: (2012)

QD-Based FRET Probes at a Glance
por: Shamirian, Armen, et al.
Publicado: (2015)

QD:Puf Nanohybrids Are Compatible with Studies in Cells
por: Wójtowicz, Karolina, et al.
Publicado: (2022)

Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation
por: Pflugrad, Henning, et al.
Publicado: (2020)

Considerations for a QD0 with Hybrid Technology in ILC
por: Modena, M, et al.
Publicado: (2014)

Cablage enroulements de correction "QF" et "QD"
por: Pasquali, J
Publicado: (1974)

Switchable Multi-Color Solution-Processed QD-laser
por: Matloub, Samiye, et al.
Publicado: (2020)

Phase II Trials in Drug Development and Adaptive Trial Design
por: Van Norman, Gail A.
Publicado: (2019)

Safety and Efficacy of Conversion from Twice-Daily Tacrolimus to Once-Daily Tacrolimus One Month after Transplantation: Randomized Controlled Trial in Adult Renal Transplantation
por: Oh, Chang-Kwon, et al.
Publicado: (2014)

Pharmacokinetics of mycophenolic acid and its phenyl glucuronide metabolite in kidney transplant recipients with renal impairment
por: Kamińska, Jolanta, et al.
Publicado: (2012)

Radiation Dose to the QD0 Quadrupole in the CLIC Interaction Region
por: Teodorescu, E, et al.
Publicado: (2011)

Research on the Force-Sensitive Characteristic of InAs QD Embedded in HEMT
por: Wang, Rui-Rong, et al.
Publicado: (2021)

Practical and Theoretical Trials of “Formagen”
por: Bauchwitz, Max
Publicado: (1898)

New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory Disease
por: Kotton, Camille Nelson, et al.
Publicado: (2022)

Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial
por: Nashan, Björn, et al.
Publicado: (2021)

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
por: Kamar, Nassim, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pbk3rf8sgokfcdaj44lv2fi6jr